| Substance | Relationship Strength | Studies | Trials | Classes | Roles |
|---|
chrysomycin a
chrysomycin A: Streptomyces arenae; differs only in sugar moiety from gilvocarcin V | 3.57 | 2 | 0 | glycoside | |
glycosides
[no description available] | 3.17 | 1 | 0 | | |
naphthoquinones
Naphthoquinones: Naphthalene rings which contain two ketone moieties in any position. They can be substituted in any position except at the ketone groups. | 3.17 | 1 | 0 | | |
landomycin a
landomycin A: structure given in first source; isolated from Streptomyces sp. | 3.17 | 1 | 0 | oligosaccharide | metabolite |
gilvocarcin v
gilvocarcin V: from Actinomycete DO-38; structure given in first source | 3.17 | 1 | 0 | | |
jadomycin a
jadomycin A: the aglycone of jadomycin B; structure in first source. jadomycin A : A organic heteropentacyclic compound that is 1,2,8,13-tetrahydro-3aH-benzo[b][1,3]oxazolo[3,2-f]phenanthridine which carries oxo groups at positions 2, 8 and 13, methyl group at position 5, hydroxy groups at positions 7 and 12, and a (2R)-butan-2-yl group at position 1. It is a mixture of epimers at the hemiaminal carbon (position 3a). | 3.17 | 1 | 0 | | |
jadomycin b
jadomycin B: structure given in first source; isolated from Streptomyces venezuelae. jadomycin B : A jadomycin that is jadomycin A in which the phenolic hydroxy group at position 12 has been converted to the corresponding 2,6-dideoxy-alpha-L-ribo-hexopyranoside, isolated from Streptomyces venezuelae. It exists as a diastereoisomeric mixture consisting of both 3aS and 3aR isomers. | 3.17 | 1 | 0 | glycoside;
jadomycin;
organic heteropentacyclic compound | antibacterial agent;
antineoplastic agent;
apoptosis inducer;
Aurora kinase inhibitor;
bacterial metabolite |
landomycin e
landomycin E: structure given in first source; isolated from Streptomyces sp. | 3.17 | 1 | 0 | oligosaccharide | |
warfarin
Warfarin: An anticoagulant that acts by inhibiting the synthesis of vitamin K-dependent coagulation factors. Warfarin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary embolism, and atrial fibrillation with embolization. It is also used as an adjunct in the prophylaxis of systemic embolism after myocardial infarction. Warfarin is also used as a rodenticide.. warfarin : A racemate comprising equal amounts of (R)- and (S)-warfarin. Extensively used as both an anticoagulant drug and as a pesticide against rats and mice.. 4-hydroxy-3-(3-oxo-1-phenylbutyl)-1-benzopyran-2-one : A member of the class of coumarins that is 4-hydroxycoumarin which is substituted at position 3 by a 1-phenyl-3-oxo-1-butyl group. | 3.17 | 1 | 0 | benzenes;
hydroxycoumarin;
methyl ketone | |
chrysomycin b
chrysomycin B: structure given in first source | 3.17 | 1 | 0 | | |
kinamycin a
kinamycin A: isolated from Streptomyces muragamaensis; RN in Chemline for Kinamycin B: 35303-13-0; RN for Kinamycin C: 35303-08-3; RN for Kinamycin D: 35303-14-1; RN given refers to parent cpd; structure | 3.17 | 1 | 0 | kinamycin | |
kinamycin f
kinamycin F: isolated from Streptomyces murayamaensis; structure given in first source | 3.17 | 1 | 0 | kinamycin | |
angucyclinone
angucyclinone: structure in first source | 3.17 | 1 | 0 | | |